![Nicholas Opie](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Nicholas Opie is the founder of Synchron, Inc. He is currently the Chief Technology Officer & Director at SmartStent Pty Ltd.
Nicholas Opie active positions
Companies | Position | Start |
---|---|---|
SmartStent Pty Ltd.
![]() SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia. | Chief Tech/Sci/R&D Officer | - |
Synchron, Inc.
![]() Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
SmartStent Pty Ltd.
![]() SmartStent Pty Ltd. Computer Processing HardwareElectronic Technology SmartStent Pty Ltd. develops medical technology for vascular bionics. The firm offers STENTRODE, a stent-based electrode array that is implanted by cerebral angiography. This minimally invasive day procedure will allow access to areas of the brain that control the movement of limbs, without having to perform open brain surgery. The company was founded by Thomas Oxley on November 30, 2012 and is headquartered in Melbourne, Australia. | Electronic Technology |
Synchron, Inc.
![]() Synchron, Inc. Packaged SoftwareTechnology Services Synchron, Inc. operates as a medical device company that develops neural interface technology. It offers Stentrode, an endovascular electrode array. The company was founded by Thomas Oxley and Nicholas Opie and is headquartered in Campbell, CA. | Technology Services |
- Stock Market
- Insiders
- Nicholas Opie